Acute tobacco smoke-induced airways inflammation in spontaneously hypertensive rats

Inhalation Toxicology

Volumn 20, Issue 7, 2008, Pages 623-633

  Yu, Bei ^a   Kodavanti, Urmila P ^b   Takeuchi, Minoru ^c   Witschi, Hanspeter ^a   Pinkerton, Kent E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

AIR; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; LUNG LAVAGE; MACROPHAGE; MALE; NEUTROPHIL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFLAMMATION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; HYPERTENSION; INFLAMMATION; LUNG DISEASES; LYMPHOCYTES; MACROPHAGES; MALE; NEUTROPHILS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SMOKE; TOBACCO;

ANIMALIA; MUS; NICOTIANA TABACUM; RATTUS; RATTUS NORVEGICUS;

EID: 45849121418     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370701861538     Document Type: Article

References (63)

1. Aharinejad, S., Schraufnagel, D. E., Bock, P., MacKay, C. A., Larson, E. K., Milksovsky, A., and Marks, S. C., Jr. 1996. Spontaneously hypertensive rats develop pulmonary hypertension and hypertrophy of pulmonary venous sphincters. Am. J. Pathol. 148:281-290.
2. Amagasa, H., Okazaki, M., Iwai, T., Kobayashi, S., and Oguchi, K. 2005. Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats. J. Atheroscler. Thromb. 12:191-198.
3. Bardales, R. H., Xie, S. S., Schaefer, R. F., and Hsu, S. M. 1996. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 149:845-852.
4. Barnes, P. J. 1999. Molecular genetics of chronic obstructive pulmonary disease. Thorax 54:245-252.
5. Barnes, P. J. 2004. Alveolar macrophages as orchestrators of COPD. COPD 1:59-70.
6. P., Listì, F., Orlando, V., Vasto, S., Caruso, M., Colonna-Romano, G., Lio, D., and Caruso, C. 2006. Inflammation, longevity, and cardiovascular diseases: Role of polymorphisms of TLR4. Ann. NY Acad. Sci. 1067:282-287.
7. Collins, R. J., Harmon, B. V., Gobe, G. C., and Kerr, J. F. 1992. Inter nucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61:451-453.
8. Dahl, M., Tybjaerg-Hansen, A., Lange, P., Vestbo, J., and Nordestgaard, B. G. 2002. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann. Intern. Med. 136:270-279.
9. Der Sarkissian, S., Marchand, E. L., Duguay, D., Hamet, P., and deBlois D. 2003. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. Cardiovasc. Res. 57:775-83.
10. Exner, M., Minar, E., Wagner, O., and Schillinger, M. 2004. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radical Biol. Med. 37:1097-1104.
11. Fornage, M., Hinojos, C. A., Nurowska, B.W., Boerwinkle, E., Hammock, B. D., Morisseau, C. H., and Doris, P. A. 2002. Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats. Hypertension. 40:485-490.
12. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
13. Gilmour, P. S., Schladweiler, M. C., Ledbetter, A.D., Samet, J. M., and Kodavanti, U. P. 2004. The hypertensive rats are susceptible to TLR-4-mediated signaling following exposure to combustion particulate matter (PM). Inhal. Toxicol. 16(Suppl. 1):5-18.
14. Gossart, S., Cambon, C., Orfila, C., Seguelas, M. H., Lepert, J. C., Rami, J., Carre, P., and Pipy, B. 1996. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica. J. Immunol. 156:1540-1548.
15. Grashoff, W. F., Sont, J. K., Sterk, P. J., Hiemstra, P. S., de Boer, W. I., Stolk, J., Han, J., and van Krieken, J. M. 1997. Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am. J. Pathol. 151:1785-1790.
16. Guerassimov, A., Hoshino, Y., Takubo, Y., Turcotte, A., Yamamoto, M., Ghezzo, H., Triantafillopoulos, A., Whittaker, K., Hoidal, J. R., and Cosio M. G. 2004. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am. J. Respir. Crit. Care Med. 170:974-980.
17. Hagimoto, N., Kuwano, K., Miyazaki, H., Kunitake, R., Fujita, M., Kawasaki, M., Kaneko, Y., and Hara, N. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17:272-278.
18. Haslett, C. 1999. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med. 160:S5-S11.
19. Hersh, C. P., DeMeo, D. L., Raby, B. A., Litonjua, A. A., Sylvia, J. S., Sparrow, D., Reilly, J. J., and Silverman, E. K. 2006. Genetic linkage and association analysis of COPD-related traits on chromosome 8p. COPD 3:189-194.
20. Hnizdo, E., Sullivan, P. A., Bang, K. M., and Wagner, G. 2002. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 156:738-746.
21. Hussain, N., Wu, F., Zhu, L., Thrall, R. S., and Kresch, M. J. 1998. Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am. J. Respir. Cell Mol. Biol. 19:867-874.
22. Jeffery, P. K. 1998. Structural and inflammatory changes in COPD: A comparison with asthma. Thorax 53:129-136.
23. Karahan, Z. C., Deda, G., Sipahi, T., Elhan, A. H., and Akar, N. 2005. TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb. Res.115:393-398.
24. Khraibi, A. A., Norman, R. A., Jr., and Dzielak, D. J. 1984. Chronic immunosuppression attenuates hypertension in Okamoto spontaneously hypertensive rats. Am. J. Physiol. 247:H722-H726.
25. Kobayashi, N., DeLano, F. A., and Schmid-Schonbein, G. W. 2005. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler. Thromb. Vasc. Biol. 25:2114-2121.
26. Kodavanti, U. P., Schladweiler, M. C., Ledbetter, A. D., Watkinson, W. P., Campen, M. J., Winsett, D. W., Richards, J. R., Crissman, K. M., Hatch, G. E., and Costa, D. L. 2000. The spontaneously hypertensive rat as a model of human cardiovascular disease: Evidence of exacerbated cardiopulmonary injury and oxidative stress from inhaled emission particulate matter. Toxicol. Appl. Pharmacol. 164:250-263.
27. Kodavanti, U. P., Schladweiler, M. C., Ledbetter, A. D., Hauser, R., Christiani, D. C., McGee, J., Richards, J. R., and Costa, D. L. 2002. Temporal association between pulmonary and systemic effects of particulate matter in healthy and cardiovascular compromised rats. J. Toxicol. Environ. Health A. 65:1545-1569.
28. Kodavanti, U. P., Schladweiler, M. C., Ledbetter, A. D., Ortuno, R. V., Suffia, M., Evansky, P., E., Jaskot, R. H., Thomas, R., Karoly, E., Huang, Y. C., Costa, D. L., Gilmour, P. S., and Pinkerton, K. E. 2006. The spontaneously hypertensive rat: An experimental model of sulfur dioxide-induced airways disease. Toxicol. Sci. 94:193-205.
29. Kurose, I., Wolf, R., Cerwinka, W., and Granger, D. N. 1999. Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats. Hypertension. 34:212-216.
30. Kuwano, K., Kunitake, R., Kawasaki, M., Nomoto, Y., Hagimoto, N., Nakanishi, Y., and Hara, N. 1996. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 15:477-483.
31. Leco, K. J., Waterhouse, P., Sanchez, O. H., Gowing, K. L., Poole, A. R., Wakeham, A., Mak, T. W., and Khokha, R. 2001. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J. Clin. Invest. 108:817-829.
32. Lee, C. R., North, K. E,, Bray, M. S., Fornage, M., Seubert, J. M., Newman, J. W., Hammock, B. D., Couper, D. J., Heiss, G., and Zeldin, D. C. 2006b. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Hum. Mol. Genet. 15:1640-1649.
33. Lee, Y. L., Chen, W., Tsai, W. K., Lee, J. C., Chiou, H. L., Shih, C. M., and Wang, Y. C. 2006a. Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. J. Lab. Clin. Med. 147:228-233.
34. Leigh, J., Wang, H., Bonin, A., Peters, M., and Ruan, X. 1997. Silica-induced apoptosis in alveolar and granulomatous cells in vivo. Environ. Health. Perspect. 105(Suppl. 5):1241-1245.
35. Lewis, C. A., Ambrose, C., Banner, K., Battram, C., Butler, K., Giddings, J., Mok, J., Nasra, J., Winny, C., and Poll, C. 2007. Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig. Pulmon. Pharmacol. Ther. 20:325-333.
36. Liu, Y., Berthier-Schaad, Y., Fallin, M. D., Fink, N. E., Tracy, R. P., Klag, M. J., Smith, M. W., and Coresh, J. 2006. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J. Am. Soc. Nephrol. 17:863-870.
37. Lopez, A. D., and Murray, C. C. 1998. The global burden of disease, 1990-2020. Nat. Med. 4:1241-1243.
38. MacNee, W. 2005a. Pathogenesis of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2:258-266.
39. MacNee, W. 2005b. Oxidants and COPD. Curr. Drug Targets Inflamm. Allergy 4:627-641.
40. Matheson, M. C., Raven, J., Walters, E. H., Abramson, M. J., and Ellis, J. A. 2006. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum. Biol. 78:705-717.
41. Matute-Bello, G., Liles, W. C., Steinberg, K. P., Kiener, P. A., Mongovin, S., Chi, E. Y., Jonas, M., and Martin, T. R. 1999. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 163:2217-2225.
42. Meurrens, K., Ruf, S., Ross, G., Schleef, R., von Holt, K., and Schlúter, K. D. 2007. Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats. Cardiovasc Res. 76:311-322.
43. Miniño, A. M., Heron, M. P., Murphy, S. L., and Kochanek, K. D. 2007. Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Deaths: Final data for 2004. Natl. Vital Stat. Rep. 55(19):1-119.
44. Moskowitz, R., and Kukin, M. 1999. Oxidative stress and congestive heart failure. Congest. Heart Fail. 5:153-163.
45. Ofulue, A. F., and Ko, M. 1999. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am. J. Physiol. Lung Cell Mol. Physiol. 21:L97-L105.
46. Polunovsky, V. A., Chen, B., Henke, C., Snover, D., Wendt, C., Ingbar, D. H., and Bitterman, P. B. 1993. Role of mesenchymal cell death in lung remodeling after injury. J. Clin. Invest. 92:388-397.
47. Rehman, I. 2005. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: Cellular and molecular mechanisms. Cell Biochem. Biophys. 43:167-88.
48. Rutgers, S. R., Postma, D. S., ten Hacken, N. H ., Kauffman, H. F., van Der Mark, T.W. , Koeter, G. H., and Timens, W. 2000. Ongoing airway inflammation in patients with COPD who do not currently smoke. Chest 117(5 Suppl. 1):262S.
49. Saetta, M., Di Stefano, A., Turato, G., Facchini, F. M., Corbino, L., Mapp, C. E., Maestrelli, P., Ciaccia, A., and Fabbri, L. M. 1998. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 15:822-826.
50. Samet, J. M. 2004. Adverse effects of smoke exposure on the upper airway. Tobacco Control 13(Suppl. 1):i57-i60.
51. Schmid-Schonbein, G. W., Seiffge, D., DeLano, F. A., Shen, K., and Zweifach, B. W. 1991. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 1:323-330.
52. Shapiro, S. D. 2000. Animal models for chronic obstructive pulmonary disease. Age of Klotho and Malboro mice. Am. J. Respir. Cell Mol. Biol. 22:4-7.
53. Smith, K. R., Uyeminami, D. L., Kodavanti, U. P., Crapo, J. D., Chang, L.Y., and Pinkerton, K. E. 2002. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radical Biol. Med. 33:1106-1114.
54. Suematsu, M., Suzuki, H., Delano, F. A., and Schmid-Schönbein, G.W. 2002. The inflammatory aspect of the microcirculation in hypertension: Oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 9:259-276.
55. Teague, S. V., Pinkerton, K. E., Goldsmith, M., Gebremichael, A., Chang, S., Jenkins, R. A., and Moneyhun, J. H. 1994. Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal. Toxicol. 6:79-83.
56. Teramoto, S., Ishii, T., Yamamoto, H., Yamaguchi, Y., and Ouchi, Y. 2005. Apoptosis of circulating neutrophils and alveolar macrophages in COPD. Chest 127:1079-1080.
57. Watt, A. P., Schock, B. C., and Ennis, M. 2005. Neutrophils and eosinophils: Clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr. Drug Targets Inflamm. Allergy 4:415-423.
58. Witschi, H., Espiritu, I., Ly, M., Uyeminami, D., Morin, D., and Raabe, O. G. 2004. Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: A pilot study. Inhal Toxicol. 16:763-770.
59. Wright, J., and Harrison, N. 1990. Cardiopulmonary effects of a brief exposure to cigarette smoke in the guinea pig. Respiration 5:70-76.
60. Wright, J. L., and Churg, A. 2002. Animal models of cigarette smoke-induced COPD. Chest 122(6 Suppl.):301S-306S.
61. Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., and Wouters, E. F. 2007. Systemic effects of smoking. Chest 131:1557-1566.
62. Zalba, G., San José, G., Beaumont, F. J., Fortuño, M. A,, Fortuño, A., and Díez, J. 2001. Polymorphisms and promoter overactivity of the p22(phox) gene in vascular smooth muscle cells from spontaneously hypertensive rats. Circ. Res. 88:217-222.
63. Zhong, C. Y., Zhou, Y. M., Douglas, G. C., Witschi, H., and Pinkerton, K. E. 2005. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26:2187-2195.